Abstract PO1-06-10: Overall survival results from EVER-132-001, a phase 2b single-arm study of sacituzumab govitecan in Chinese patients with metastatic triple-negative breast cancer
Ma, Fei, Wang, Shusen, Tong, Zhongsheng, Li, Wei, Wu, Xinhong, Wang, Xiaojia, Sun, Tao, Pan, Yueyin, Yao, Herui, Wang, Xian, Luo, Ting, Yang, Jin, Zeng, Xiaohua, Zhao, Weihong, Komatsubara, Kimberly, Nakamura, Rachel, Lai, Catherine, Zhang, Bo, Cong, Xiuyu, Xu, Binghe
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Get full text
Journal Article